Danny Tomassini’s Post

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/4ghmY0r

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/3ZXixC8

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/3ZVxIf9

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/4fqMijk

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/49IsWVN

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/4iFdFJu

Discover why CDMO support is essential for solo launches and how it can drive industry success. Dive into the full article from RSM senior life sciences analyst Amanda Laskey! #Medtech #LifeSciences #CDMO https://rsm.buzz/3DbQfuP

🚨 Are You Ready for the Biggest Change in Laboratory Developed Tests (LDTs)? The FDA’s new ruling on LDTs is shaking up the industry, and its impact will be felt across labs, manufacturers, and ultimately, patient care. On the latest episode of The Med-Tech Talent Lab, I had the privilege of speaking with Julie Ballard, a seasoned clinical laboratory expert with over 25 years of leadership in startups and biotech giants like GRAIL and Genomic Health. Julie shares: 🔍 The key distinctions between LDTs and FDA-approved tests ⚖️ What the new FDA ruling means for labs and compliance 💡 Practical steps labs should take to adapt and thrive This is a must-listen for anyone navigating the evolving regulatory landscape. Link to full episode & all the others (almost 115) in the comments. What are your thoughts on the new ruling? Let me know in the comments! Thanks for being a valued guest on the show, Julie! -MR Joshua D. Levin, Heather Thompson, M.S., RAC, CQA, CMQ- OE Kelly Gordon, PhD, MB(ASCP), RAC-Devices, Brent Murphy #MedTech #Diagnostics #LDT #regulatoryaffairs #quality #medtechtalentlab

🚨 Attending #dPharma in Philly? 📍 Transform your clinical trials with #TrialsSphere and our GenAI-powered beta launch! 🚀 ✅ Revolutionize protocol creation – Use GenAI to rapidly generate, refine, and optimize clinical trial protocols in record time. ✅ Adapt in real-time – Implement protocol amendments seamlessly with AI-driven precision, reducing delays and errors. ✅ Cut costs – Save valuable time and resources by automating the entire protocol development process. The future of clinical trials is here. Are your protocols ready for it? 👉 Join the beta now: trialssphere.com/home #GenAI #AIinPharma #PharmaInnovation #ClinicalTrials #DigitalHealth #ClinicalResearch #AI

Boston Scientific had its quarterly earning call yesterday (July 24th). ProntoNLP's #GenAI platform analyzed the earning call transcript and found a bullish trend. The overall #LLM score stayed the same as last quarter (0.86) but is at a local maximum for the last 5 quarters. 28 of the #LLM categories improved compared with the previous quarter while just 16 #LLM categories declined. The Forecast #LLM category improved compared with the last quarter and is at a local maximum for the past 5 quarters. Analysts had an overwhleming majority of positive questions comments (18 positive vs. 2 negative). ProntoNLP provides via SFTP real time #quant signals on earning calls, filings, macro and news. Reach out to ProntoNLP to start using our #GenAI based tools and stay ahead of the curve. #stockpicking #portfoliomanagement #quantitativefinance